Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
PET Clinics
|
April 30, 2026
Fibroblast Activation Protein: Molecular Imaging and Beyond
Sophie C Siegmund, Rudolf A Werner, Frederik L Giesel
Cancers
|
August 28, 2025
Metabolic Imaging in Electrochemotherapy: Insights from FDG-PET Analysis in Metastatic Melanoma-A Pilot Study
Sophie C Siegmund, Maximilian Deußing, Rudolf A Werner, et al.
Nuklearmedizin. Nuclear Medicine
|
February 25, 2026
Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck
Sophie C Siegmund, Sebastian E Serfling, Takahiro Higuchi, et al.
Seminars in Nuclear Medicine
|
October 16, 2025
Recent Advances and Future Trends of[<sup>18</sup>F]-Labeled PET Agents for Renal Imaging
Takahiro Higuchi, Xinyu Chen, Sophie C Siegmund, et al.
Seminars in Nuclear Medicine
|
December 27, 2025
Current status of FAP therapy in solid tumors
Sophie C Siegmund, Emil Novruzov, Eduards Mamlins, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2026
Systematic evaluation of response and adverse events in mCRPC patients treated with different combinations of [<sup>225</sup>Ac]Ac/[<sup>177</sup>Lu]Lu-PSMA-therapy
Gabriel T Sheikh, Sophie C Siegmund, Liam Widjaja, et al.
Diagnostics (Basel, Switzerland)
|
August 28, 2025
Prognostic Value of Automated Bone Scan Index (aBSI) in Patients with mCRPC Undergoing Three vs. Six Cycles of <sup>223</sup>Ra Therapy
Sophie C Siegmund, Harun Ilhan, Antonia Gerull, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 26, 2026
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [<sup>177</sup>Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 1, 2025
Refining the clinical utility of [<sup>177</sup>Lu]Lu/[<sup>225</sup>Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2026
Estimation of split renal function on PET using the SSTR-targeting radioligands [<sup>18</sup>F]SiTATE, [<sup>68</sup>Ga]Ga-DOTA-TATE and [<sup>68</sup>Ga]Ga-DOTA-TOC in a theranostic setting
Maximilian Tiling, Lena M Unterrainer, Sophie C Siegmund, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
PET Clinics
|
April 30, 2026
Fibroblast Activation Protein: Molecular Imaging and Beyond
Sophie C Siegmund, Rudolf A Werner, Frederik L Giesel
Cancers
|
August 28, 2025
Metabolic Imaging in Electrochemotherapy: Insights from FDG-PET Analysis in Metastatic Melanoma-A Pilot Study
Sophie C Siegmund, Maximilian Deußing, Rudolf A Werner, et al.
Nuklearmedizin. Nuclear Medicine
|
February 25, 2026
Emerging Theranostic Targets in Squamous Cell Carcinoma of the Head and Neck
Sophie C Siegmund, Sebastian E Serfling, Takahiro Higuchi, et al.
Seminars in Nuclear Medicine
|
October 16, 2025
Recent Advances and Future Trends of[<sup>18</sup>F]-Labeled PET Agents for Renal Imaging
Takahiro Higuchi, Xinyu Chen, Sophie C Siegmund, et al.
Seminars in Nuclear Medicine
|
December 27, 2025
Current status of FAP therapy in solid tumors
Sophie C Siegmund, Emil Novruzov, Eduards Mamlins, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 13, 2026
Systematic evaluation of response and adverse events in mCRPC patients treated with different combinations of [<sup>225</sup>Ac]Ac/[<sup>177</sup>Lu]Lu-PSMA-therapy
Gabriel T Sheikh, Sophie C Siegmund, Liam Widjaja, et al.
Diagnostics (Basel, Switzerland)
|
August 28, 2025
Prognostic Value of Automated Bone Scan Index (aBSI) in Patients with mCRPC Undergoing Three vs. Six Cycles of <sup>223</sup>Ra Therapy
Sophie C Siegmund, Harun Ilhan, Antonia Gerull, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 26, 2026
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [<sup>177</sup>Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 1, 2025
Refining the clinical utility of [<sup>177</sup>Lu]Lu/[<sup>225</sup>Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer
Liam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 15, 2026
Estimation of split renal function on PET using the SSTR-targeting radioligands [<sup>18</sup>F]SiTATE, [<sup>68</sup>Ga]Ga-DOTA-TATE and [<sup>68</sup>Ga]Ga-DOTA-TOC in a theranostic setting
Maximilian Tiling, Lena M Unterrainer, Sophie C Siegmund, et al.
Page
of 2